190 related articles for article (PubMed ID: 35840155)
1. Canadian Rheumatology Association Living Guidelines for the Pharmacological Management of Rheumatoid Arthritis With Disease-Modifying Antirheumatic Drugs.
Hazlewood GS; Pardo JP; Barnabe C; Schieir O; Barber CEH; Proulx L; Richards DP; Tugwell P; Bansback N; Akhavan P; Bombardier C; Bykerk V; Jamal S; Khraishi M; Taylor-Gjevre R; Thorne JC; Agarwal A; Pope JE
J Rheumatol; 2022 Oct; 49(10):1092-1099. PubMed ID: 35840155
[TBL] [Abstract][Full Text] [Related]
2. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
[TBL] [Abstract][Full Text] [Related]
3. Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.
Bykerk VP; Akhavan P; Hazlewood GS; Schieir O; Dooley A; Haraoui B; Khraishi M; Leclercq SA; Légaré J; Mosher DP; Pencharz J; Pope JE; Thomson J; Thorne C; Zummer M; Bombardier C;
J Rheumatol; 2012 Aug; 39(8):1559-82. PubMed ID: 21921096
[TBL] [Abstract][Full Text] [Related]
4. Australian recommendations on tapering of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in inflammatory arthritis.
Whittle SL; Glennon V; Johnston RV; Avery JC; Bell JS; Brennan SE; Fong C; Hissaria P; Horgan B; O'Neill S; Pisaniello HL; Trevena L; Whittaker GA; Wluka A; Buchbinder R
Intern Med J; 2022 Oct; 52(10):1799-1805. PubMed ID: 35567366
[TBL] [Abstract][Full Text] [Related]
5. Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: part II safety.
Bombardier C; Hazlewood GS; Akhavan P; Schieir O; Dooley A; Haraoui B; Khraishi M; Leclercq SA; Légaré J; Mosher DP; Pencharz J; Pope JE; Thomson J; Thorne C; Zummer M; Gardam MA; Askling J; Bykerk V;
J Rheumatol; 2012 Aug; 39(8):1583-602. PubMed ID: 22707613
[TBL] [Abstract][Full Text] [Related]
6. Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis-secondary publication.
Kawahito Y; Morinobu A; Kaneko Y; Kohno M; Hirata S; Kishimoto M; Seto Y; Sugihara T; Tanaka E; Ito H; Kojima T; Matsushita I; Nishida K; Mori M; Murashima A; Yamanaka H; Nakayama T; Kojima M; Harigai M
Mod Rheumatol; 2023 Jan; 33(1):21-35. PubMed ID: 35297492
[TBL] [Abstract][Full Text] [Related]
7. 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
Louthrenoo W; Kasitanon N; Katchamart W; Aiewruengsurat D; Chevaisrakul P; Chiowchanwisawakit P; Dechanuwong P; Hanvivadhanakul P; Mahakkanukrauh A; Manavathongchai S; Muangchan C; Narongroeknawin P; Phumethum V; Siripaitoon B; Suesuwan A; Suwannaroj S; Uea-Areewongsa P; Ukritchon S; Asavatanabodee P; Koolvisoot A; Nanagara R; Totemchokchyakarn K; Nuntirooj K; Kitumnuaypong T
Int J Rheum Dis; 2017 Sep; 20(9):1166-1184. PubMed ID: 28730640
[TBL] [Abstract][Full Text] [Related]
8. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
Singh JA; Saag KG; Bridges SL; Akl EA; Bannuru RR; Sullivan MC; Vaysbrot E; McNaughton C; Osani M; Shmerling RH; Curtis JR; Furst DE; Parks D; Kavanaugh A; O'Dell J; King C; Leong A; Matteson EL; Schousboe JT; Drevlow B; Ginsberg S; Grober J; St Clair EW; Tindall E; Miller AS; McAlindon T;
Arthritis Care Res (Hoboken); 2016 Jan; 68(1):1-25. PubMed ID: 26545825
[TBL] [Abstract][Full Text] [Related]
9. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
Arthritis Care Res (Hoboken); 2017 Aug; 69(8):1111-1124. PubMed ID: 28620917
[TBL] [Abstract][Full Text] [Related]
10. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
J Arthroplasty; 2017 Sep; 32(9):2628-2638. PubMed ID: 28629905
[TBL] [Abstract][Full Text] [Related]
11. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
Singh JA; Saag KG; Bridges SL; Akl EA; Bannuru RR; Sullivan MC; Vaysbrot E; McNaughton C; Osani M; Shmerling RH; Curtis JR; Furst DE; Parks D; Kavanaugh A; O'Dell J; King C; Leong A; Matteson EL; Schousboe JT; Drevlow B; Ginsberg S; Grober J; St Clair EW; Tindall E; Miller AS; McAlindon T
Arthritis Rheumatol; 2016 Jan; 68(1):1-26. PubMed ID: 26545940
[TBL] [Abstract][Full Text] [Related]
12. EULAR definition of difficult-to-treat rheumatoid arthritis.
Nagy G; Roodenrijs NMT; Welsing PM; Kedves M; Hamar A; van der Goes MC; Kent A; Bakkers M; Blaas E; Senolt L; Szekanecz Z; Choy E; Dougados M; Jacobs JW; Geenen R; Bijlsma HW; Zink A; Aletaha D; Schoneveld L; van Riel P; Gutermann L; Prior Y; Nikiphorou E; Ferraccioli G; Schett G; Hyrich KL; Mueller-Ladner U; Buch MH; McInnes IB; van der Heijde D; van Laar JM
Ann Rheum Dis; 2021 Jan; 80(1):31-35. PubMed ID: 33004335
[TBL] [Abstract][Full Text] [Related]
13. Canadian Rheumatology Association Recommendation for the Use of COVID-19 Vaccination for Patients With Autoimmune Rheumatic Diseases.
Hazlewood GS; Pardo JP; Barnabe C; Schieir O; Barber CEH; Bernatsky S; Colmegna I; Hitchon C; Loeb M; Mertz D; Proulx L; Richards DP; Scuccimarri R; Tugwell P; Schünemann HJ; Mirza RD; Zhou AL; Nikolic RPA; Thomas M; Chase H; Ejaredar M; Nieuwlaat R
J Rheumatol; 2021 Aug; 48(8):1330-1339. PubMed ID: 33993119
[TBL] [Abstract][Full Text] [Related]
14. 2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis.
England BR; Smith BJ; Baker NA; Barton JL; Oatis CA; Guyatt G; Anandarajah A; Carandang K; Chan KK; Constien D; Davidson E; Dodge CV; Bemis-Dougherty A; Everett S; Fisher N; Fraenkel L; Goodman SM; Lewis J; Menzies V; Moreland LW; Navarro-Millan I; Patterson S; Phillips LR; Shah N; Singh N; White D; AlHeresh R; Barbour KE; Bye T; Guglielmo D; Haberman R; Johnson T; Kleiner A; Lane CY; Li LC; Master H; Pinto D; Poole JL; Steinbarger K; Sztubinski D; Thoma L; Tsaltskan V; Turgunbaev M; Wells C; Turner AS; Treadwell JR
Arthritis Care Res (Hoboken); 2023 Aug; 75(8):1603-1615. PubMed ID: 37227116
[TBL] [Abstract][Full Text] [Related]
15. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.
Smolen JS; Landewé R; Bijlsma J; Burmester G; Chatzidionysiou K; Dougados M; Nam J; Ramiro S; Voshaar M; van Vollenhoven R; Aletaha D; Aringer M; Boers M; Buckley CD; Buttgereit F; Bykerk V; Cardiel M; Combe B; Cutolo M; van Eijk-Hustings Y; Emery P; Finckh A; Gabay C; Gomez-Reino J; Gossec L; Gottenberg JE; Hazes JMW; Huizinga T; Jani M; Karateev D; Kouloumas M; Kvien T; Li Z; Mariette X; McInnes I; Mysler E; Nash P; Pavelka K; Poór G; Richez C; van Riel P; Rubbert-Roth A; Saag K; da Silva J; Stamm T; Takeuchi T; Westhovens R; de Wit M; van der Heijde D
Ann Rheum Dis; 2017 Jun; 76(6):960-977. PubMed ID: 28264816
[TBL] [Abstract][Full Text] [Related]
16. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
Smolen JS; Landewé RBM; Bijlsma JWJ; Burmester GR; Dougados M; Kerschbaumer A; McInnes IB; Sepriano A; van Vollenhoven RF; de Wit M; Aletaha D; Aringer M; Askling J; Balsa A; Boers M; den Broeder AA; Buch MH; Buttgereit F; Caporali R; Cardiel MH; De Cock D; Codreanu C; Cutolo M; Edwards CJ; van Eijk-Hustings Y; Emery P; Finckh A; Gossec L; Gottenberg JE; Hetland ML; Huizinga TWJ; Koloumas M; Li Z; Mariette X; Müller-Ladner U; Mysler EF; da Silva JAP; Poór G; Pope JE; Rubbert-Roth A; Ruyssen-Witrand A; Saag KG; Strangfeld A; Takeuchi T; Voshaar M; Westhovens R; van der Heijde D
Ann Rheum Dis; 2020 Jun; 79(6):685-699. PubMed ID: 31969328
[TBL] [Abstract][Full Text] [Related]
17. Prescribing trends in disease modifying antirheumatic drugs for rheumatoid arthritis: a survey of practicing Canadian rheumatologists.
Pope JE; Hong P; Koehler BE
J Rheumatol; 2002 Feb; 29(2):255-60. PubMed ID: 11838842
[TBL] [Abstract][Full Text] [Related]
18. 2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis.
England BR; Smith BJ; Baker NA; Barton JL; Oatis CA; Guyatt G; Anandarajah A; Carandang K; Chan KK; Constien D; Davidson E; Dodge CV; Bemis-Dougherty A; Everett S; Fisher N; Fraenkel L; Goodman SM; Lewis J; Menzies V; Moreland LW; Navarro-Millan I; Patterson S; Phillips LR; Shah N; Singh N; White D; AlHeresh R; Barbour KE; Bye T; Guglielmo D; Haberman R; Johnson T; Kleiner A; Lane CY; Li LC; Master H; Pinto D; Poole JL; Steinbarger K; Sztubinski D; Thoma L; Tsaltskan V; Turgunbaev M; Wells C; Turner AS; Treadwell JR
Arthritis Rheumatol; 2023 Aug; 75(8):1299-1311. PubMed ID: 37227071
[TBL] [Abstract][Full Text] [Related]
19. 2014 update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritis.
Sanmartí R; García-Rodríguez S; Álvaro-Gracia JM; Andreu JL; Balsa A; Cáliz R; Fernández-Nebro A; Ferraz-Amaro I; Gómez-Reino JJ; González-Álvaro I; Martín-Mola E; Martínez-Taboada VM; Ortiz AM; Tornero J; Marsal S; Moreno-Muelas JV
Reumatol Clin; 2015; 11(5):279-94. PubMed ID: 26051464
[TBL] [Abstract][Full Text] [Related]
20. Emerging issues in pharmacological management of rheumatoid arthritis: results of a national needs assessment survey identifying practice variations for the development of Canadian Rheumatology Association clinical practice recommendations.
Bykerk VP; Schieir O; Akhavan P; Hazlewood GS; Cheng CK; Bombardier C
J Rheumatol; 2012 Aug; 39(8):1555-8. PubMed ID: 21885494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
